FI64377B - Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat Download PDF

Info

Publication number
FI64377B
FI64377B FI772280A FI772280A FI64377B FI 64377 B FI64377 B FI 64377B FI 772280 A FI772280 A FI 772280A FI 772280 A FI772280 A FI 772280A FI 64377 B FI64377 B FI 64377B
Authority
FI
Finland
Prior art keywords
acid
mixture
reduced pressure
under reduced
compound
Prior art date
Application number
FI772280A
Other languages
English (en)
Finnish (fi)
Other versions
FI772280A (sv
FI64377C (fi
Inventor
Yoshio Kuroda
Masakuni Okuhara
Eiko Iguchi
Hatsuo Aoki
Hiroshi Imanaka
Takashi Kamiya
Masashi Hashimoto
Keiji Hemmi
Hidekazu Takeno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI772280A publication Critical patent/FI772280A/fi
Priority to FI821745A priority Critical patent/FI70594C/fi
Publication of FI64377B publication Critical patent/FI64377B/fi
Application granted granted Critical
Publication of FI64377C publication Critical patent/FI64377C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

1 II H-N-A-P- OR3 (Ie) OR3 84 64377 jossa R2, R3 ja A tarkoittavat samaa kuin edellä, saatetaan reagoimaan asylointiaineen, jonka kaava on RgOH, jossa R^ on edellä määritelty, tai sen reaktiivisen johdannaisen kanssa, 6. yhdiste, jonka kaava Ig on OH O , t II Ri-N-A-P-OH (Ig) a I OH jossa R^ ja A tarkoittavat samaa kuin edellä, saatetaan reagoimaan bentsoehapon tai sen reaktiivisen johdannaisen kanssa, 7. yhdiste, jonka kaava li on OR2 O , i n R--N-A-P - OH (li) a I OH jossa Rg, R2 ja A tarkoittavat samaa kuin edellä, tai sen suola tai sen reaktiivinen johdannainen fosfonoryhmässä, saatetaan reagoimaan alemman alkanolin tai sen reaktiivisen johdannaisen kanssa ja tarvittaessa saatu kaavan I mukainen yhdiste, jossa R3 on vety, muutetaan happoadditiosuolaksi. Il· 85 64377 Förfarande för framställning av farmakologiskt värdefulla hydroxi-aminokolvätefosfonsyraderivat med den allmänna formeln I OR2 Q i 1 n , Rx - N - A - P - OR3 (I) OR3 där R3· är väte, lägre alkanoyl, som kan vara substituerad med en eller flere hydroxi- eller halogengrupper, lägre alkenovl, bensovl, tienyl(lägre)alkanoyl, eller fenylglyoxyloyl, 2 ·· R ar vate, lägre alkyl, fenyl(lägre)alkyl eller läqre alkanoyl, lägre alkoxikarbonyl eller bensoyl, som kan innehälla haloqen, A är lägre alkylen, lägre alkenylen eller hydroxi(läqre)alkylen, O ee R ar vate eller lägre alkyl eller dess sait, kännetecknat därav, att 1. en förening med formeln IV OR2 R1 - NH (IV) ••1 2 dar R och R avser detsamma som ovan, omsätts med en föreninq med formeln V 0 2. ii 3 - A - P - OR3 (V) OR3 där R3 och A avser detsamma som ovan och X2 Sr syrarest, 2. en förening med formeln VI 86 64377 O O
4. Ho R4 = N- A- P- 0R| (VI) I o 0r3 där R3 och A avser detsamma soin ovan och R4 är en alkyl iden, hydrolyseras, 3. en föreninq med formeln la OR2 O
1. II o R1 - N - A - P - 0R| (la) TOO där R , R , R^ och A avser detsamma som ovan hydrolyseras, 4. en föreninq med formeln Id OR2 0 ΐ ΐ π o Rf-N-A-P - OR-3 (Id) a I , 0RJ där R2, R3 och A avser detsamma som ovan, och R^ avser detsamma som R^- med undantag av väte, hydrolyseras, 5. en förening med formeln Ie OR2 0 I a II , H-N-A-P - OR-3 (Ie) OR3 dar R^, R och A avser detsamma som ovan, omsätts med ett li
FI772280A 1976-07-27 1977-07-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat FI64377C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI821745A FI70594C (fi) 1976-07-27 1982-05-18 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminkolvaetefosfonsyraderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB3133976 1976-07-27
GB4222276 1976-10-11
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
GB2570077 1977-06-20

Publications (3)

Publication Number Publication Date
FI772280A FI772280A (sv) 1978-01-28
FI64377B true FI64377B (fi) 1983-07-29
FI64377C FI64377C (fi) 1983-11-10

Family

ID=27258468

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772280A FI64377C (fi) 1976-07-27 1977-07-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat

Country Status (21)

Country Link
US (1) US4182758A (sv)
JP (1) JPS5340720A (sv)
AR (1) AR226522A1 (sv)
AT (2) AT367064B (sv)
CA (1) CA1091241A (sv)
CH (5) CH640862A5 (sv)
DE (2) DE2733658A1 (sv)
DK (1) DK149609C (sv)
ES (3) ES461084A1 (sv)
FI (1) FI64377C (sv)
FR (1) FR2474505A1 (sv)
GB (1) GB1580899A (sv)
GR (1) GR61140B (sv)
HU (1) HU182023B (sv)
IE (1) IE45536B1 (sv)
NL (1) NL7708325A (sv)
NO (1) NO157504C (sv)
OA (1) OA05725A (sv)
PH (1) PH14401A (sv)
PT (1) PT66854B (sv)
SE (1) SE441360B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (sv) * 1989-08-31 1991-04-18
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
TR200002965T2 (tr) 1998-04-14 2001-05-21 Jomaa,Hassan Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
AP2001002051A0 (en) 1998-07-15 2001-03-31 Hassan Jomaa Phosphorous organic compounds and their use.
AU5034899A (en) * 1998-07-15 2000-02-07 Jomaa Hassan Drugs containing phosphoric acid derivatives as active ingredient and their use
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
WO2001060829A1 (de) * 2000-02-18 2001-08-23 Jomaa Pharmaka Gmbh Phosphororganische verbindungen und ihre verwendung
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
US20080300222A1 (en) * 2005-10-06 2008-12-04 Innate Pharma Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
WO2007088878A1 (ja) * 2006-01-31 2007-08-09 Api Corporation ベンゾアゼピノン類の製造方法
AU2009276343A1 (en) 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (en) 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
WO2019246119A1 (en) * 2018-06-18 2019-12-26 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Antibiotics for veterinary staphylococcal infections
EP4045056A1 (de) 2019-10-19 2022-08-24 DMG Deutsche Malaria GmbH Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit clindamycin und artesunat
EP3960176A1 (en) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine and related drug combinations for use in the treatment of covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (sv) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
JPS613799B2 (sv) 1986-02-04
PT66854A (en) 1977-08-01
AT367430B (de) 1982-07-12
FI772280A (sv) 1978-01-28
GB1580899A (en) 1980-12-10
ES479211A1 (es) 1979-12-16
NO772652L (no) 1978-01-30
DE2760320C2 (sv) 1988-11-03
IE45536L (en) 1978-01-27
GR61140B (en) 1978-09-23
ATA550977A (de) 1981-10-15
DK337877A (da) 1978-01-28
ES461084A1 (es) 1978-12-01
US4182758A (en) 1980-01-08
CH647807A5 (de) 1985-02-15
NO157504B (no) 1987-12-21
DK149609C (da) 1987-02-09
CA1091241A (en) 1980-12-09
DK149609B (da) 1986-08-11
AR226522A1 (es) 1982-07-30
JPS5340720A (en) 1978-04-13
DE2733658A1 (de) 1978-02-09
ES471822A1 (es) 1979-10-16
HU182023B (en) 1983-12-28
SE7708592L (sv) 1978-01-28
NL7708325A (nl) 1978-01-31
CH640862A5 (de) 1984-01-31
FR2474505B1 (sv) 1984-01-27
SE441360B (sv) 1985-09-30
PT66854B (en) 1978-12-28
FI64377C (fi) 1983-11-10
OA05725A (fr) 1981-05-31
IE45536B1 (en) 1982-09-22
PH14401A (en) 1981-06-25
AT367064B (de) 1982-05-25
CH646978A5 (de) 1984-12-28
NO157504C (no) 1988-03-30
FR2474505A1 (fr) 1981-07-31
CH646980A5 (de) 1984-12-28
ATA564879A (de) 1981-11-15
DE2733658C2 (sv) 1987-06-25
CH646979A5 (de) 1984-12-28

Similar Documents

Publication Publication Date Title
FI64377B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat
US4206156A (en) Hydroxyaminohydrocarbonphosphonic acids
RU2266909C2 (ru) Водорастворимые азольные соединения и способ их получения
US8404664B2 (en) Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections
LU83117A1 (fr) Antibiotiques a noyau beta-lactame,et procede pour les preparer
JP2009114202A (ja) ホスフォノセフェム誘導体、その製造法および用途
JPH0351716B2 (sv)
RU1826970C (ru) Способ получени производных пептидов WS-9326 А
EP0099553A2 (en) Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
CA2133444A1 (en) Novel acylated phospholipid drugs
JP2004518640A (ja) 水溶性アゾール化合物の改良された方法
US5620969A (en) Cephalosporin derviatives
KR20000057283A (ko) 세팔로스포린 유도체
SE453400B (sv) Forfarande for framstellning av fosfonsyraderivat genom odling av en stam horande till streptomyces rubellomurinus, streptomyces rubellomurinus subsp. indigoferus eller streptomyces lavendulae
US4325951A (en) 1-Oxadethiacephalosporin derivatives and antibacterial use thereof
US5006515A (en) Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein
KR820000104B1 (ko) 신규 하이드록시아미노 하이드로 카르본포스폰산 유도체의 제조방법
KR820001611B1 (ko) 신규 하이드록시아미노 하이드로 카르본 포스폰산 유도체의 제조방법
HUT73769A (en) New cephalosporins containing a substituted benzyloxyimino radical in position 7, their preparation process, their use as medicaments
KR820001610B1 (ko) 신규 하이드록시아미노 하이드로카르본포스폰산 유도체의 제조방법
US4365066A (en) 2(4-n-Hexadecyl amino or oxy phenyl) 5 ethoxy oxazoleacetic acid derivatives
KR810000288B1 (ko) 몬산 및 이소몬산 유도체의 제조방법
HU176880B (en) Process for pproducing new ceph-3-eme-4-carboxylic acid derivatives
FR2530635A1 (fr) Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres
HUT69683A (en) New cephem compounds of antimicrobial activity

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD.